Eli Lilly voiced support for the government proposal to end the rebates made to pharmacy benefit managers, Reuters reported. According to the article, the manufacturer said that the plan could lower the cost of insulin and other highly-rebated prescription drugs for patients. Lilly and other insulin makers Sanofi SA and Novo Nordisk have faced increasing pressure over the rising cost of insulin products, the article reported.
A recent observational study found that the incidence of cancer linked to obesity is on the rise in young adults, The American Journal of Managed Care reported. According to the article, the researchers assessed data on invasive cases of cancer diagnosed in patients aged 25 to 84 years between 1995 and 2014, focusing on 12 obesity-related cancer types. During the study period, the incidences of multiple myeloma and cancers of the colorectum, corpus uteri, gallbladder, kidney, pancreas, and thyroid all increased in younger adults, the article reported.